Cagrisema is a medicine for weight loss and weight maintenance that contains the active substance Semaglutide and Cagrilintide. Semaglutide is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. Semaglutide works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. Cagrilintide is a long-acting amylin analogue that is currently being investigated for its potential use in the treatment of obesity and related metabolic conditions. It mimics the effects of the natural hormone amylin. When both Semaglutide and Cagrilinitide are used together the overall efficacy is enhanced greatly. The most apparent result will be enhanced weightloss much greater than that of Semaglutide on its own.
This product contains both Semaglutide and Cagrlintide. When selecting a dosage on the pen unit for example 0.25mg. This will dispense 0.25mg of Semaglutide and 0.25mg of Cagrilintide at the same time.
 
Cagrisema 12 offers a promising solution for those looking to manage their weight and blood sugar levels effectively. However, it should always be used under the guidance of a healthcare professional to ensure the best results and avoid potential side effects.